Keyphrases
Tel Aviv
68%
Israel
66%
Post-stroke
60%
Cognitive Decline
54%
C-C Chemokine Receptor Type 5 (CCR5)
48%
Methadone Maintenance Treatment
48%
Tabasco
39%
Brain Atrophy
36%
Prospective Cohort Study
35%
Cognitive Impairment
35%
Depressive Symptoms
34%
Transient Ischemic Attack
33%
Protective Factors
32%
Impaired Renal Function
32%
Maraviroc
32%
Consensus Document
32%
Premenstrual Dysphoric Disorder
32%
Medical Center
30%
Stroke Survivors
28%
Stroke Ischemic
25%
Cognitive Outcome
24%
Acute Stroke
23%
Clock Drawing Test
23%
Posttraumatic Stress Symptoms
22%
Post-stroke Depression
20%
Survivors
20%
Functional Magnetic Resonance Imaging
20%
Tertiary General Hospital
19%
Ischemic Stroke
19%
Cortisol Level
19%
Vascular Dementia
19%
Proof of Concept Study
19%
Treatment Options
18%
Risk Factors
18%
Abstinence
18%
Treatment Strategy
16%
Interns
16%
Immune Markers
16%
Screening Kits
16%
Acute Psychosis
16%
Opiate Addiction
16%
Las Vegas
16%
Brain Alterations
16%
Outcome after Stroke
16%
Emergency Room
16%
Psychiatric Consultation
16%
Salivary Cortisol
16%
Bedtime
16%
COVID-19
16%
Clinical Trials
16%
Medicine and Dentistry
Apoplexy
100%
Cognitive Defect
53%
Depression
32%
Maraviroc
32%
Cerebral Atrophy
32%
Protective Factor
32%
Transient Ischemic Attack
28%
Cerebrovascular Disease
28%
Symptom
25%
Cohort Analysis
19%
Post-Stroke Depression
19%
Prospective Cohort Study
19%
Diagnosis
19%
Brain Ischemia
18%
Vascular Dementia
17%
Magnetic Resonance Imaging
17%
Clock Drawing Test
16%
Hydrocortisone
16%
Acute Psychosis
16%
Emotional Dysregulation
16%
Clinical Trial
16%
Alzheimer's Disease
16%
Kidney Function
16%
Mental Health
16%
Late Life Depression
16%
COVID-19
16%
Randomized Clinical Trial
16%
Neuromodulation
16%
Premenstrual Dysphoric Disorder
16%
Neurofeedback
16%
Sense of Agency
16%
Psychological First Aid
16%
Creatinine Clearance
13%
Mild Cognitive Impairment
10%
Loss of Function Mutation
10%
Magnetic Resonance Imaging
10%
Biological Marker
10%
Adverse Event
9%
Montgomery-Åsberg Depression Rating Scale
8%
Geriatric Depression Scale
8%
Cerebrospinal Fluid
7%
Mental Deterioration
7%
Placebo
6%
Positive and Negative Syndrome Scale
6%
Chemokine Receptor
5%
Prospective Study
5%
Gamma Chemokine
5%
Antidepressant
5%
Prevention of Dementia
5%
Genetic Marker
5%
Neuroscience
Cognitive Disorders
60%
Methadone
48%
CCR5
35%
Cortisol
32%
Depression
32%
Cerebrovascular Disease
31%
Transient Ischemic Attack
31%
Creatinine
24%
Opiate
21%
Posttraumatic Stress Disorder
21%
Magnetic Resonance Imaging
21%
Brain Ischemia
20%
Vascular Dementia
19%
Premenstrual Dysphoric Disorder
16%
Acute Psychosis
16%
Maraviroc
16%
Diabetes Mellitus
16%
Opioid Dependence
16%
Alzheimer's Disease
16%
Neuromodulation
16%
Positive Syndrome
16%
Meta-Analysis
16%
Late Life Depression
16%
Neurofeedback
16%
Internet Addiction
16%
Psychiatric Service
16%
Psychiatry
16%
Burnout
16%
Magnetic Resonance Imaging
15%
Mild Cognitive Impairment
14%
Sleep Quality
13%
Negative Syndrome
12%
Loss of Function Mutation
11%
Physical Dependence
10%
Cognitive State
10%
Placebo
9%
Psychosis
8%
Acute Stress Reaction
8%
Acute Stress Disorder
8%
Mental Deterioration
8%
Geriatric Depression Scale
7%
Cognitive Tests
7%
Apolipoprotein E4
6%
Benzodiazepine
5%
Brain Function
5%
Gamma Chemokine
5%
Chemokine Receptor
5%
Genetic Marker
5%
Vascular Disease
5%
Structural Protein
5%
